1. Home
  2. NRP vs BCYC Comparison

NRP vs BCYC Comparison

Compare NRP & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRP
  • BCYC
  • Stock Information
  • Founded
  • NRP 2002
  • BCYC 2009
  • Country
  • NRP United States
  • BCYC United Kingdom
  • Employees
  • NRP N/A
  • BCYC N/A
  • Industry
  • NRP Coal Mining
  • BCYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NRP Energy
  • BCYC Health Care
  • Exchange
  • NRP Nasdaq
  • BCYC Nasdaq
  • Market Cap
  • NRP 1.4B
  • BCYC 1.7B
  • IPO Year
  • NRP N/A
  • BCYC 2019
  • Fundamental
  • Price
  • NRP $105.23
  • BCYC $15.14
  • Analyst Decision
  • NRP
  • BCYC Buy
  • Analyst Count
  • NRP 0
  • BCYC 9
  • Target Price
  • NRP N/A
  • BCYC $36.00
  • AVG Volume (30 Days)
  • NRP 31.6K
  • BCYC 880.7K
  • Earning Date
  • NRP 11-05-2024
  • BCYC 10-31-2024
  • Dividend Yield
  • NRP 2.88%
  • BCYC N/A
  • EPS Growth
  • NRP 4.50
  • BCYC N/A
  • EPS
  • NRP 12.60
  • BCYC N/A
  • Revenue
  • NRP $256,666,000.00
  • BCYC $36,898,000.00
  • Revenue This Year
  • NRP N/A
  • BCYC $40.52
  • Revenue Next Year
  • NRP N/A
  • BCYC N/A
  • P/E Ratio
  • NRP $8.26
  • BCYC N/A
  • Revenue Growth
  • NRP N/A
  • BCYC 48.60
  • 52 Week Low
  • NRP $81.74
  • BCYC $12.17
  • 52 Week High
  • NRP $113.04
  • BCYC $28.67
  • Technical
  • Relative Strength Index (RSI)
  • NRP 47.89
  • BCYC 28.66
  • Support Level
  • NRP $105.05
  • BCYC $12.17
  • Resistance Level
  • NRP $109.32
  • BCYC $21.50
  • Average True Range (ATR)
  • NRP 3.24
  • BCYC 1.33
  • MACD
  • NRP -0.76
  • BCYC -0.46
  • Stochastic Oscillator
  • NRP 30.03
  • BCYC 31.83

About NRP Natural Resource Partners LP Limited Partnership

Natural Resources Partners LP is a diversified natural resource company. It is engaged in the business of owning, managing and leasing a diversified portfolio of mineral properties in the United States, including interests in coal, trona and soda ash, crude oil and natural gas, construction aggregates, frac sand, and other natural resources. The company leases coal reserves to experience mine operators under long-term leases that grant the operator the right to mine its coal reserves in exchange for royalty payments. The company operates in two reportable segments namely: Mineral Rights and Soda Ash. the majority of the revenue is generated from the Mineral Rights segment. The business activity of the group functions through the United States.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.

Share on Social Networks: